Krebs von den Lungen-6 glycoprotein circulating levels are not useful as prognostic marker in COVID-19 pneumonia: A large prospective cohort study

Coronavirus disease 2019 (COVID-19) has rapidly expanded worldwide. Currently, there are no biomarkers to predict respiratory worsening in patients with mild to moderate COVID-19 pneumonia. Small studies explored the use of Krebs von de Lungen-6 circulating serum levels (sKL-6) as a prognostic bioma...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ivan Castellví, Diego Castillo, Hèctor Corominas, Anaís Mariscal, Sandra Orozco, Natividad Benito, Virginia Pomar, Andrés Baucells, Isabel Mur, David de la Rosa-Carrillo, David Lobo, Ana Milena Millan, Nerea Hernández de Sosa, David Filella, Laia Matas, Laura Martínez-Martínez, Cándido Juarez, Jordi Casademont, Pere Domingo
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-08-01
Edice:	Frontiers in Medicine
Témata:	COVID-19 Krebs von den Lungen-6 (KL-6) pneumonia biomarker predictor
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fmed.2022.973918/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!